ZA733035B - Compounds of the pregnane series having anaesthetic activity - Google Patents

Compounds of the pregnane series having anaesthetic activity

Info

Publication number
ZA733035B
ZA733035B ZA733035A ZA733035A ZA733035B ZA 733035 B ZA733035 B ZA 733035B ZA 733035 A ZA733035 A ZA 733035A ZA 733035 A ZA733035 A ZA 733035A ZA 733035 B ZA733035 B ZA 733035B
Authority
ZA
South Africa
Prior art keywords
compounds
pregnane series
anaesthetic activity
anaesthetic
activity
Prior art date
Application number
ZA733035A
Other languages
English (en)
Inventor
C Newall
G Phillipps
R Lawrence
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of ZA733035B publication Critical patent/ZA733035B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
ZA733035A 1972-05-05 1973-05-04 Compounds of the pregnane series having anaesthetic activity ZA733035B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
ZA733035B true ZA733035B (en) 1974-04-24

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA733035A ZA733035B (en) 1972-05-05 1973-05-04 Compounds of the pregnane series having anaesthetic activity

Country Status (16)

Country Link
JP (1) JPS4961150A (de)
AT (1) AT355232B (de)
AU (1) AU475168B2 (de)
BE (1) BE799102A (de)
CA (1) CA1013341A (de)
CH (1) CH617710A5 (de)
DE (1) DE2322532A1 (de)
ES (1) ES414411A1 (de)
FR (1) FR2183792B1 (de)
GB (1) GB1430942A (de)
IE (1) IE37596B1 (de)
IL (1) IL42196A (de)
LU (1) LU67546A1 (de)
NL (1) NL7306234A (de)
SE (1) SE400771B (de)
ZA (1) ZA733035B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5939545A (en) 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
ES2296594T3 (es) * 1994-02-14 2008-05-01 Euro-Celtique S.A. Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
EP3572417A3 (de) 2011-10-14 2020-03-25 Sage Therapeutics, Inc. 3,3-disubstituierte 19-nor-pregnan verbindungen, zusammensetzungen damit und verwendungen davon
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
IL304912A (en) 2012-08-21 2023-10-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
RU2700264C2 (ru) 2013-04-17 2019-09-16 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
KR102239541B1 (ko) 2013-04-17 2021-04-14 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
EP3868382A1 (de) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Neuroaktive steroide, zusammensetzungen und verwendungen davon
LT3488852T (lt) 2013-08-23 2021-02-25 Sage Therapeutics, Inc. Neuroaktyvūs steroidai, kompozicijos, ir jų naudojimas
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
BR112017007902B1 (pt) 2014-10-16 2023-12-05 Sage Therapeutics, Inc Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
SI3224269T1 (sl) 2014-11-27 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
WO2017156103A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
DE2322532A1 (de) 1973-11-22
GB1430942A (en) 1976-04-07
BE799102A (fr) 1973-11-05
LU67546A1 (de) 1973-07-13
IE37596B1 (en) 1977-08-31
ATA395173A (de) 1979-07-15
CH617710A5 (en) 1980-06-13
FR2183792B1 (de) 1977-07-15
IE37596L (en) 1973-11-05
NL7306234A (de) 1973-11-07
JPS4961150A (de) 1974-06-13
AU475168B2 (en) 1976-08-12
AT355232B (de) 1980-02-25
SE400771B (sv) 1978-04-10
IL42196A0 (en) 1973-07-30
IL42196A (en) 1978-10-31
CA1013341A (en) 1977-07-05
AU5528473A (en) 1974-11-07
ES414411A1 (es) 1976-02-01
FR2183792A1 (de) 1973-12-21

Similar Documents

Publication Publication Date Title
ZA733218B (en) Compounds of the pregnene series having anaesthetic activity
ZA733035B (en) Compounds of the pregnane series having anaesthetic activity
MY8000222A (en) Diapers
ZA739325B (en) Manufacture of activated carbon
AU6294173A (en) Therapeutic composition
ZA734037B (en) Compounds of the androstane series having anaesthetic activity
KR780000095B1 (en) Proless for the preparation of 1-hydroxy-2-pyridiones
ZA73577B (en) Benzylidenesemicarbazide compounds having insecticidal activity
CA1010847A (en) Compounds of the pregnane series having useful anaesthetic activity and processes for their preparation
ZA732336B (en) Respirator
IL41310A0 (en) The preparation of 3-carbamoyloxy-methyl cephalosphorins
IL42716A0 (en) Disinfectant
CA995662A (en) Compounds of the pregnane series having useful anaesthetic activity and processes for their preparation
CA979885A (en) Compounds of the pregnane series having useful anaesthetic activity and process for their preparation
ZA737787B (en) Disposable humidifier
IL42256A0 (en) The use of certain beta-acyl-aryl-hydrazines as fungicides
ZA733036B (en) Compounds of the pregnane series having anaesthetic activity
IL43078A0 (en) The preparation of 5-isopropyl-3-methyl-phenol
ZA733037B (en) Compounds of the pregnane series having anaesthetic activity
CA992068A (en) Steroid having anaesthetic activity
ZA73129B (en) Chemosterilization of ixodides
IL42503A0 (en) Compounds of the androstane series having anaesthetic activity
AU475165B2 (en) Treatment of respiration conditions using hydroxycyclohexylamino compounds
ZA717449B (en) Compounds of the pregnane series having useful anaesthetic activity
IL42257A0 (en) The use of certain amilides as fungicides